U

Equashield

Closed-system Transfer Devices for Safe Handling of Hazardous Drugs
Startup Acquired Founded 2009 Health Tech & Life Sciences
Last Update Aug 21, 2024

Equashield News

2 articles
Oct 6, 2022 · www.calcalistech.com
growth-positive
Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation | CTech
Israeli company Equashield has sold a 25% stake to private equity firm Nordic Capital for $300 million, giving it a valuation of $1.3 billion and making it a unicorn. Equashield, founded in 2008, provides manual and automated solutions for the compounding and administration of hazardous drugs to hospitals worldwide. The deal marks Nordic Capitals first investment in an Israeli company. Prior to the deal, Equashield distributed approximately $28 million in dividends to its shareholders. The companys largest shareholder is CEO and co-founder Eric Shem-Tov.
Investment
Aug 25, 2022 · www.prnewswire.com
growth-positive
Equashield's State-of-the-Art Manufacturing Complex Fulfilling Customer Orders at Record Pace
Equashield, a leading provider of closed system transfer devices (CSTDs) for hazardous drugs, announced that its automated manufacturing facility is helping the company fulfill large quantity customer orders on-time, neutralizing global supply chain challenges. The facility, equipped with machine learning and artificial intelligence, allows for fully automated production and quick supply fulfillment. Equashields CSTD portfolio provides safety and ease of use for healthcare workers handling hazardous drugs. The companys growth and investment in manufacturing technology have paid off, enabling them to meet market demands and ensure quality assurance.
Customers